Abstract
Alexithymia presents a deficit in identifying and expressing emotions, paucity of fantasies, and an externally oriented cognitive style. Numerous recent studies have documented that alexithymia is significantly related to dysregulation of immune functions. These findings implicate that stressors related to alexithymia could underlie the process of immune dysregulation that likely presents a significant risk factor in pathogenesis of several psychosomatic illnesses. In this article various findings on immune dysregulation in alexithymia are reviewed and discussed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Agarwal, S. K., & Marshall, G. D. Jr. (2001). Dexamethasone promotes type 2 cytokine production primarily though inhibition of type 1 cytokines. Journal of Inter-feron and Cytokine Research, 21, 147–55.
Alexander, F. (1943). Fundamental concepts of psychosomatic research. Psychosomatic Medicine, 5, 205–10.
Alexander, F. (1950). Psychosomatic Medicine. New York: Norton.
Beresnevaite, M. (2000). Exploring the benefits of group psychotherapy in reducing alexithymia in coronary hearth disease patients. Psychotherapy and Psy-chosomatics, 69, 117–22.
Bermond, B. (1997). Brain and Alexithmia. In: Vingerhoets AJJM, van Bussel FJ, Boelhouwer A. JW, editors. The (non)expression of emotions in health and disease. Tilburg, The Nederlands: Tilburg University Press. p. 115–29.
Bossù, P., Salani, F., Cacciari, C., Picchetto, L., Cao, M., Bizzoni, F., Rasura, M., Caltagirone, C., Robinson, R. G., Orzi, F., & Spalletta, G. (2009). Disease Outcome, Alexithymia and Depression are Differently Associated with Serum IL-18 Levels in Acute Stroke. Current Neurovascular Research, 6(3), 163–70.
Bruni, R., Serino, F. M., Galluzzo, S., Coppolino, G., Cacciapaglia, F., Vadacca, M., Nilo, S., Terminio, N., & Afeltra, A. (2006). Alexithymia and neuroendocrineimmune response in patients with autoimmune diseases: preliminary results on relationship between alexithymic construct and TNF-alpha levels. Annals of the New York Academy of Science, 1069, 208–11.
Caioppo, J. T., Berntson, G. C., Malarkey, W. B., Kiecolt-Glaser, J. K., Sheridan, J. F., Poehlmann, K. M., Burleson, M. H., Ernst, J. M., Hawkley, L. C., & Laser, R. (1998). Autonomic, neuroendocrine, and immune responses to psychological stress: the reactivity hypothesis. Annals of the New York Academy of Sciences, 840, 664–73.
Corcos, M., Guilbaud, O., Paterniti, S., Curt, F., Hjalmarsson, L., Moussa, M., Chambry, J., Loas, G., Chaouat, G., & Jeammet, P. (2004). Correlation between serum levels of interleukin-4 and alexithymia scores in healthy female subjects: preliminary findings. Psychoneuroendocrinology, 29(4), 557–62.
De Timary, P., Roy, E., Luminet, O., Fille, C., & Mikolajczak, M. (2008). Relationship between alexithymia, alexithymia factors and salivary cortisol in men exposed to a social stress test. Psychoneuroendocrinology, 33(8), 1160–4.
Dewaraja, R., Tanigawa, T., Araki, S., Nakata, A., Kawamura, N., Ago, Y., & Sasaki, Y. (1997). Decreased cytotoxic lymphocyte counts in alexithymia. Psychotherapy and Psychosomatics, 66(2), 83–6.
Elenkov, I. J., Papanicolaou, D. A., Wilder, R. L., & Chrousos, G. P. (1996). Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proceedings of the Association of American Physicians, 108, 374–81.
Elenkov, I. J. & Chrousos, G. P. (2002). Stress Hormones, Proinflammantory and Antiinflammantory cyto-kines, and Autoimmunity. Annals of the New York Academy of Sciences, 966, 290–303.
Friedlander, L., Lumley, M. A., Farchione, T., & Doyal, G. (1997). Testing the alexithymia hypothesis: physiological and subjective responses during relaxation and stress. The Journal of Nervous and Mental Disease, 185(4), 233–9.
Fukunishi, I., Sei, H., Merita, Y., & Rahe, R. H. (1999). Sympathetic activity in alexithymics with mother’s low care. Journal of Psychosomatic Research, 46, 579–89.
Gabbard, G., O. (2000). A neurobiologically informed perspective on psychotherapy. British Journal of Psychiatry, 177, 117–122.
Gay, M. C., Hanin, D., & Luminet, O. (2008). Effectiveness of an hypnotic imaginery intervention on reducing alexithymia. Contemporary Hypnosis, 25, 1–13.
Glaser, R., MacCallum, R. C., Laskowski, B. F., Malar-key, W. B., Sheridan, J. F., & Kielcolt-Glaser, J. K. (2001). Evidence for a shift in the Th-1 to Th-2 cyto-kine response associated with chronic stress and aging. [published erratum appears in Journal of Gerontology: Medical Sciences, 56(11), M673]. Journal of Gerontology: Biological Sciences, 56, M477–82.
Grabe, H. J., Frommer, J., Ankerhold, A., Ulrich, C., Groger, R., Franke, G. H., Barnow, S., Freyberger, H. J., & Spitzer, C. (2008). Alexithymia and outcome in psychotherapy. Psychotherapy and Psychosomatics, 77(3), 189–94.
Guilbaud, O., Corcos, M., Hjalmarsson, L., Loas, G., & Jeammet, P. (2003). Is there a psychoneuroimmunological pathway between alexithymia and immunity? Immune and physiological correlates of alexithymia. Biomedicine and Pharmacotherapy, 57(7), 292–5.
Guilbaud O, Curt F, Perrin C, Chaouat G, Berthoz S, Dugré-Le Bigre, C., Wallier, J., Strebler, M., Touitou, C, Jeammet, P., & Corcos, M. (2009). Decreased immune response in alexithymic women: A cross-sectional study. Biomedicine and Pharmacotherapy, 63(4), 297–304.
Gundel, H., Greiner, A., Ceballos-Baumann, A. O., Von Rad, M., Forstl, H., & Jahn, T. (2002). Increased level of tonic sympathetic arousal in high versus low alexi-thymic cervical dystonia patients. Psychoterapy and Psychosomatics, 52, 461–8.
Infrasca, R. (1997). Alexithymia, neurovegetative arousal and neuroticism. An experimental study. Psychotherapy and Psychosomatics, 66(5), 76–280.
Kandel, E. R. (1998). A new intellectual framework for psychiatry. American Journal of Psychiatry, 155, 457–469.
Kennedy, M., & Franklin, J. (2002). Skills-based treatment for alexithymia: An exploratory case series. Behavioral Changes, 19, 158–171.
Kiecolt-Glasser, J. K., McGuire, L., Nobles, T. F., & Laser, R. (2002). Psychoneuroimmunology and Psychosomatic Medicine: Back to the Future, Psychosomatic Medicine, 64, 15–28.
Lane, R. D., Ahern, G. L., Schwarz, G. E., & Kaszniak, A. W. (1997). Is alexithymia the Emotional Equivalent of Blindsight? Biological Psychiatry, 42, 834–44.
Lin, S., Zhao, S. F., & Yan, F. H. (2005). The influence of alexithymia in stress on secretory IgA and cortisol in saliva. Shanghai Kou Qiang Yi Xue, 14(6), 561–4.
Locatelli, V., Bresciani, E., Tamiazzo, L. & Torsello, A. (2010). Central Nervous System-Acting Drugs Influencing Hypothalamic-Pituitary-Adrenal Axis Function. Endocrine Development, 17, 108–120.
Lumley, M. A., Stettner, L., & Wehmer, F. (1996). How are alexithymia and physical illness linked? A review and critique of pathways. Journal of Psychosomatic Research, 41, 505–18.
Marques, A. H., Silverman, M. N. & Sternberg, E. M. (2009). Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics. Annals of the New York Academy of Sciences, 1179, 1–18.
Marshall, G. D., Agarwall, S. K., Lloyd, C., Cohen, L., Henninger, E. M., & Morris, G. J. (1998). Cytokine dysregulation associated with exam stress in healthy medical students. Brain, Behavior, and Immunity, 12, 297–307.
Martin, J. B., & Pihl, R. (1985). The stress-alexithymia hypothesis: Theoretical and empirical considerations. Psychotheraphy and Psychosomatics, 43, 169–176.
Martin, J. B., & Pihl, R. O. (1986). Influence of alexithymic characteristics on physiological and subjective stress responses in normal individuals. Psychotherapy and Psychosomatics, 45, 66–7.
Martin, J. B, Pihl, R. O., Zouny, S. N., Ervin, F. R., & Tourjman, S. V. (1986). Prediction of alexithymic chracteristics from physiological, personality, and subjective measures. Psychotherapy and Psychosomatics, 45, 133–40.
Nemiah, J. C. & Sifneos, P. E. (1970). Affect and fantasy in patients with psychosomatic disorder. In: Hill OW, editor. Modern Trends in Psychosomatic Medicine, vol. 2. New York: Appleton-Century-Crofts. 26–34.
Nemiah, J. C. (1975). Denial revisited: Reflections on psychosomatic theory. Psychotherapy and Psychosomatics, 24, 140–7.
Nemiah, J. C. (2000). A Psychodynamic View of Psychosomatic Medicine. Psychosomatic Medicine, 62, 299–303.
Papciak, A. S., Feuerstein, M., & Spiegel, J. A. (1985). Stress reactivity in alexithymia: decoupling of physiological and cognitive responses. Journal of Human Stress, 1, 135–42.
Pedrosa, Gil F., Nickel, M., Ridout, N., Schwarz, M. J., Schoechlin, C., & Schmidmaier, R. (2007). Alexithymia and interleukin variations in somatoform disorder. Neuroimmunomodulation, 14(5), 235–42.
Rabavilas, A. D. (1987). Electrodermal activity in low and high alexithymic neurotic patients. Psychotherapy and Psychosomatice, 47, 101–104.
Sifneos, P. E. (1972). Short-Term Psychotherapy and Emotional Crisis. Cambridge, MA: Harvard University Press.
Sifneos, P. E. (1975). Problems of psychotherapy of patients with alexithymic characteristics and physical disease. Psychotherapy and Psychosomatics, 26, 65–70.
Simha-Alpern, A. (2007). ‘I finally have words!’ Integrating a psychodynamic psychotherapeutic approach with principles of emotional intelligence training in treating trama survivors. Journal of Psychotherapy Integration, 17, 293–313.
Taylor, G. J. (1987). Psychosomatic medicine and Contemporary Psychoanalysis. Madison (CT): International Universities Press.
Temoshok, L. R., Waldstein, S. R., Wald, R. L., Garzino-Demo, A., Synowski, S. J., Sun, L., & Wiley, J. A. (2008). Type C coping, alexithymia, and heart rate reactivity are associated independently and differentially with specific immune mechanisms linked to HIV progression. Brain, Behavior, and Immunity, 22(5), 781–92.
Todarello, O., Casamassima, A., Marinaccio, M., La Pesa, M. W., Caradonna, L., Valentino, L., & Marinaccio, L. (1994). Alexithymia, immunity and cervical intraepithelial neoplasia: a pilot study. Psychotherapy and Psychosomatics, 61(3-4), 199–204.
Todarello, O., Casamassima, A., Daniele, S., Marinaccio, M., Fanciullo, F., Valentino, L., Tedesco, N., Wiesel, S., Simone, G., & Marinaccio, L. (1997). Alexithymia, immunity and cervical intraepithelial neoplasia: replication. Psychotherapy and Psychosomatics, 66(4), 208–13.
Vadacca, M., Bruni, R., Cacciapaglia, F., Serino, F., Arcarese, L., Buzzulini, F., Coppolino, G., Rigon, A., Terminio, N., & Afeltra, A. (2008). Alexithymia and immunoendocrine parameters in patients affected by systemic lupus erythematosus and rheumatoid arthritis. Reumatismo, 60(1), 50–6.
Zarković, M., Ignjatović, S., Dajak, M., Cirić, J., Beleslin, B., Savić, S., Stojković, M., Bulat, P. & Trbojević, B. (2008). Cortisol response to ACTH stimulation correlates with blood interleukin 6 concentration in healthy humans. European Journal of Endocrinology, 159(5), 649–52.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Uher, T. Alexithymia and Immune Dysregulation: A Critical Review. Act Nerv Super 52, 40–44 (2010). https://doi.org/10.1007/BF03379564
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03379564